37951-15-8

Usage

Uses

Used in Pharmaceutical Industry:
4-phenoxy-1,2-benzenedicarboxylic acid is utilized as a key intermediate in the synthesis of pharmaceuticals due to its potential biological activity. It is particularly considered for the development of anti-cancer and anti-inflammatory drugs, where its chemical structure can be manipulated to target specific biological pathways.
Used in Dye Industry:
In the dye industry, 4-phenoxy-1,2-benzenedicarboxylic acid is employed as a building block for the creation of various dyes. Its chemical properties allow for the production of dyes with specific color characteristics and stability.
Used in Polymer Industry:
4-phenoxy-1,2-benzenedicarboxylic acid is used as a monomer or intermediate in the production of polymers. Its incorporation into polymer chains can influence the polymer's properties, such as strength, flexibility, and durability.
Used in Fragrance Industry:
As an intermediate in the production of fragrances, 4-phenoxy-1,2-benzenedicarboxylic acid contributes to the development of unique scents and aromas. Its chemical structure can be modified to create a variety of olfactory profiles for use in perfumes, cosmetics, and other scented products.
Used in Plastics and Resins Industry:
4-phenoxy-1,2-benzenedicarboxylic acid is used as a plasticizer in the manufacturing of plastics and resins. It helps to increase the flexibility and workability of these materials, making them suitable for a wide range of applications.

Upstream product

• 31643-49-9 4-Nitrophthalonitrile 
• 108-95-2 phenol 
• 38791-62-7 4-phenoxyphthalonitrile 
• 52509-74-7 3,4-dimethylphenyl phenyl ether 

Downstream Products

• 1421312-36-8 [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)amino]acetic acid methyl ester 
• 1421312-35-7 4-hydroxy-1-methyl-7-phenoxy-3-isoquinolinecarboxylic acid 
• 1421312-34-6 4-hydroxy-1-methyl-7-phenoxyisoquinolinyl-3-carboxylic acid methyl ester 
• 1421312-33-5 methyl 4-hydroxy-1-chloro-7-phenoxyisoquinoline-3-carboxylate 
• 1421312-32-4 C₁₇H₁₃NO₅ 
• 1421312-31-3 C₁₈H₁₃NO₆ 
• 808118-40-3 [(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)-amino]-acetic acid 
• 38791-58-1 4-phenoxyphthalic acid diethyl ester 
• 21345-01-7 4-phenoxyphthalic anhydride 
• 123466-48-8 5-phenoxy-isoindoline-1,3-dione-1,3-diimine 

Relevant academic research and scientific papers

PROCESS FOR THE PREPARATION OF ROXADUSTAT AND ITS INTERMEDIATES

The present invention provides the process for the preparation of Roxadustat and its intermediates. Another aspect of the present invention provides a process for preparation of ethyl-5-(2-butoxycarbonyl)-4-phenoxyphenyl) oxazole-4-carboxylate of the formula (X) and its use in the preparation of Roxadustat. Another aspect of the present invention provides a process for the preparation of ethyl-4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carboxylate of the formula (XIII) and its use in the preparation of Roxadustat.

Lipophilic N-Hydroxyphthalimide Catalysts for the Aerobic Oxidation of Cumene: Towards Solvent-Free Conditions and Back

A new class of lipophilic N-hydroxyphthalimide (NHPI) catalysts designed for the aerobic oxidation of cumene in solvent-free conditions was synthesized and tested. The specific strategy proposed for the introduction of lipophilic tails on the NHPI moiety

CRYSTAL TYPES OF COMPOUNDS INHIBITING ACTIVITY OF PROLYL HYDROXYLASE AND USE THEREOF

The invention relates to crystal types of compound shown as structural formula I, methods of preparing the compound, intermediate, pharmaceutical composition, and use of treating disease or pharmaceutical preparations for treating disease.

POLYMORPHIC FORMS OF COMPOUNDS AS PROLYL HYDROXYLASE INHIBITOR, AND USES THEREOF

The present invention relates to the polymorphic forms of the compound of Formula (I), preparation thereof including the preparation of intermediates and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder o

POLYMORPHIC FORMS OF COMPOUNDS AS PROLYL HYDROXYLASE INHIBITOR, AND USES THEREOF

The present invention relates to the polymorphic forms of the compound of Formula (I), preparation thereof including the preparation of intermediates and pharmaceutical compositions, and use of a polymorph above in the treatment of a disease, a disorder o

Novel nitrogen-containing heteroaryl compounds and methods of use thereof

The present invention relates to compounds suitable for use in mediating hypoxia inducible factor and for treating erythropoietin-associated conditions by increasing endogenous erythropoietin in vitro and in vivo.